Abstract
Common use of pivalate-generating antibiotics in newborns in Japan and low cutoff value of C5-acylcarnitine (C5) to detect mild forms of isovaleric acidemia (IVA) led to 1,065 positive results from IVA screening among 146,000 newborns tested by tandem mass spectrometry over the last 3 years. Using our method to determine isovalerylglycine (IVG) levels in dried blood spots (DBS) as a second-tier test with IVG cutoff value of 0.5 nmol/ml in DBS, one patient with severe IVA was identified, and no recall of the second DBS was needed. Retrospective analysis revealed that most patients with moderate to severe forms of IVA have decreased free-carnitine levels shortly after birth and higher levels of IVG than those of C5, which suggests that this method is useful in evaluating the severity of IVA. Another second-tier test, to measure methylmalonic acid (MMA) levels in DBS by gas chromatography/mass spectrometry (GC/MS), has been developed to overcome difficulties in screening methylmalonic aciduria (MMAU) and propionic acidemia. Methanol extract from DBS was dried and derivatized using N-methyl-N-(tert-butyldimethylsilyl)-trifluoroacetamide. GC/MS was performed using splitless injection, electron-impact ionization, and selected ion monitoring for data recording. MMAU patients had much higher DBS concentrations of MMA (24.2–321.9 nmol/ml) than control newborns (0.34 ± 0.11 nmol/ml). MMA measurement in DBS was thought to provide useful information about the severity of MMAU, as MMAU patients with high levels of MMA had decreased levels of free carnitine and mildly increased levels of propionylcarnitine.
Similar content being viewed by others
Abbreviations
- C2:
-
Acetylcarnitine
- C3:
-
Propionylcarnitine
- C5:
-
Acylcarnitine with 5-carbon-atom acyl group
- DBS:
-
Dried blood spot
- GC/MS:
-
Gas chromatography-mass spectrometry
- IVA:
-
Isovaleric acidemia
- IVG:
-
Isovalerylglycine
- LC:
-
Liquid chromatography
- MS/MS:
-
Tandem mass spectrometry
- MMA:
-
Methylmalonic acid
- MMAU:
-
Methylmalonic aciduria
- PA:
-
Propionic acidemia
- PGA:
-
Pivalate-generating antibiotics
- SIM:
-
Selected ion monitoring
References
Campbell CD, Ganesh J, Ficicioglu C (2005) Two newborns with nutritional vitamin B12 deficiency: challenges in newborn screening for vitamin B12 deficiency. Haematologica 90(Suppl):ECR45
Ensenauer R, Vockley J, Willard JM et al (2004) A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 75:1136–1142
Kuhara T, Shinka T, Inoue Y et al (1999) Pilot study of gas chromatographic-mass spectrometric screening of newborn urine for inborn errors of metabolism after treatment with urease. J Chromatogr B Biomed Sci Appl 731:141–147
la Marca G, Malvagia S, Pasquini E et al (2007) Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. Clin Chem 53:1364–1369
Lindner M, Ho S, Kölker S et al (2008) Newborn screening for methylmalonic acidurias-optimization by statistical parameter combination. J Inherit Metab Dis 31:379–385
Marble M, Copeland S, Khanfar N et al (2008) Neonatal vitamin B12 deficiency secondary to maternal subclinical pernicious anemia: identification by expanded newborn screening. J Pediatr 152:731–733
Shigematsu Y, Hirano S, Hata I et al (2002) Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J Chromatogr B 776:39–48
Shigematsu Y, Hata I, Tanaka Y et al (2005) Stable-isotope dilution gas chromatography-mass spectrometric measurement of 3-hydroxyglutaric acid, glutaric acid and related metabolites in body fluids of patients with glutaric aciduria type 1 found in newborn screening. J Chromatogr B 823:7–12
Shigematsu Y, Hata I, Tanaka Y (2007) Stable-isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia. Clin Chim Acta 386:82–86
Sniderman LC, Lambert M, Giguère R et al (1999) Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J Pediatr 134:675–682
Tajima G, Sakura N, Yofune H et al (2005) Establishment of a practical enzymatic assay method for determination of isovaleryl-CoA dehydrogenase activity using high-performance liquid chromatography. Clin Chim Acta 353:193–199
Vockley J, Ensenauer R (2006) Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity. Am J Med Genet C Semin Med Genet 142C(2):95–103
Wiley V, Carpenter K, Wilcken B (1999) Newborn screening with tandem mass spectrometry: 12 months’ experience in NSW Australia. Acta Paediatr Suppl 88:48–51
Yorifuji T, Kawai M, Muroi J et al (2002) Unexpectedly high prevalence of the mild form of propionic acidemia in Japan: presence of a common mutation and possible clinical implications. Hum Genet 111:161–165
Acknowledgments
This study was supported in part by a Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, and grants from The Ministry of Health, Labor, and Welfare of Japan. The authors are very grateful to Dr. Y. Kobayashi (Shimane University), Dr. Y. Okano (Osaka City University), Dr. T. Ohnishi (Tokushima Municipal Hospital), Dr. N. Ishige (Tokyo Health Service Association), Dr. E. Naito (Tokushima University), and Dr. Y. Nishida (Kurashiki Central Hospital) for their assistance in the retrospective study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Piero Rinaldo
References to electronic databases: Isovaleric acidemia: OMIM #243500, methylmalonyl-CoA mutase deficiency: OMIM #25100.
Competing interest: None declared.
Rights and permissions
About this article
Cite this article
Shigematsu, Y., Hata, I. & Tajima, G. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria. J Inherit Metab Dis 33 (Suppl 2), 283–288 (2010). https://doi.org/10.1007/s10545-010-9111-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-010-9111-9